NORWALK, Conn.--(BUSINESS WIRE)--IMS Health (NYSE: RX) today announced the launch of Ask IMSTM, a cost-effective, Web-based service that provides strategic market intelligence to help drive the growth and success of early-stage biopharmaceutical companies. Drawn from IMS’s comprehensive pharmaceutical market information, Ask IMS offers timely decision-making support for understanding critical market opportunities and issues, as well as for planning and executing successful commercialization strategies.
